| Financial Year |
March 31 2023 |
| Monetary Funds |
379,901,626.31 |
| Held-for-trading Financial Assets |
6,019,872.17 |
| Notes Receivable |
5,075,000.00 |
| Accounts Receivable |
516,808,463.94 |
| Advances to Suppliers |
36,429,753.46 |
| Other Receivables |
76,508,262.90 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
11,914,369.82 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
4,474,932.88 |
| Other Current Assets |
3,057,700.69 |
| Total Current Assets |
2,595,250,692.16 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
91,155,028.04 |
| Investment Properties |
-- |
| Fixed Assetes |
196,167,295.00 |
| Under-construction Projects |
10,044,640.79 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
18,105,111.43 |
| R&D expenses |
1,065,223.64 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
828,360.21 |
| Deferred Income Tax Assets |
37,559,559.76 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
376,428,438.94 |
| Total Assets |
2,971,679,131.10 |
| Short-Term Loans |
36,162,618.72 |
| Trading Financial liabilities |
-- |
| Notes Payable |
162,778,592.58 |
| Accounts Payable |
933,656,630.20 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
2,708,536.64 |
| Taxes Payable |
7,610,829.06 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
25,462,840.04 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
14,436,749.89 |
| Other Current Liabilities |
407,577,950.71 |
| Sub-Total of Current Liabilities |
1,672,232,538.29 |
| Long-term Loans |
62,421,449.75 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
2,626,542.33 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
494,523.05 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
111,150,536.53 |
| Total Liabilities |
1,783,383,074.82 |
| Paid-In Capital(Or Share Stock) |
142,656,479.00 |
| Capital Surplus |
415,369,047.37 |
| Surplus Reserve |
61,612,433.41 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
522,595,512.67 |
| Minority Stockholder's Interest |
46,062,583.83 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,142,233,472.45 |
| Owner's Equity（Stockholder's Equity） |
1,188,296,056.28 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,971,679,131.10 |
